|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001347,
umls-concept:C0017262,
umls-concept:C0018966,
umls-concept:C0034693,
umls-concept:C0035820,
umls-concept:C0185117,
umls-concept:C0205054,
umls-concept:C0333361,
umls-concept:C1446409,
umls-concept:C1515655,
umls-concept:C2911684
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-5-19
|
|
pubmed:abstractText |
Acute-phase protein synthesis in the liver during inflammation is regulated via cytokines and glucocorticoids. Using quantitative reverse transcription (RT)-PCR analysis and immunoassay, we explored, in the rat, the response of the acute-phase protein, alpha-2 macroglobulin (A2M), after systemic inflammation induced by lipopolysaccharide (LPS) or localized inflammation induced by turpentine oil (TO). The results indicate that synthesis of A2M is higher following TO-induced inflammation than LPS-induced inflammation and is not correlated with interleukin (IL)-6 or glucocorticoid levels. We studied the putative role of heme in this differential A2M expression following localized vs. systemic inflammation; addition of heme during LPS-induced inflammation can boost the expression of A2M, whereas blocking heme synthesis (by succinyl acetone) or enhancing its consumption in parallel biosynthetic pathways (cytochrome P450 induction by phenobarbital) decreases A2M expression. This decrease was abolished by exogenous heme supplementation. Finally, we demonstrate that heme supplementation is also able to increase the A2M response in female rats to a level similar to that in male rats providing a new insight into the puzzling sexual dimorphism observed previously during localized inflammation. We propose that heme should be considered a new regulatory element in controlling liver A2M expression during inflammation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0014-2956
|
|
pubmed:author |
pubmed-author:BogardCC,
pubmed-author:DaveauMM,
pubmed-author:DeybachJ CJC,
pubmed-author:GauthierFF,
pubmed-author:HironMM,
pubmed-author:LebretonJ PJP,
pubmed-author:LeplingardAA,
pubmed-author:LyoumiSS,
pubmed-author:NordmannYY,
pubmed-author:PuyHH,
pubmed-author:ScottéMM,
pubmed-author:TamionFF,
pubmed-author:VranckxRR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
261
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
190-6
|
|
pubmed:dateRevised |
2007-7-23
|
|
pubmed:meshHeading |
pubmed-meshheading:10103050-Acute-Phase Proteins,
pubmed-meshheading:10103050-Animals,
pubmed-meshheading:10103050-Base Sequence,
pubmed-meshheading:10103050-Cytochrome P-450 Enzyme System,
pubmed-meshheading:10103050-DNA Primers,
pubmed-meshheading:10103050-Female,
pubmed-meshheading:10103050-Gene Expression,
pubmed-meshheading:10103050-Heme,
pubmed-meshheading:10103050-Heme Oxygenase (Decyclizing),
pubmed-meshheading:10103050-Heme Oxygenase-1,
pubmed-meshheading:10103050-Inflammation,
pubmed-meshheading:10103050-Liver,
pubmed-meshheading:10103050-Male,
pubmed-meshheading:10103050-Phenobarbital,
pubmed-meshheading:10103050-RNA, Messenger,
pubmed-meshheading:10103050-Rats,
pubmed-meshheading:10103050-Rats, Sprague-Dawley,
pubmed-meshheading:10103050-alpha-Macroglobulins
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Heme and acute inflammation role in vivo of heme in the hepatic expression of positive acute-phase reactants in rats.
|
|
pubmed:affiliation |
Institut National de la Santé et de la Recherche Médicale (INSERM U-78) et Institut Fédératif de Recherches Multidisciplinaires sur les Peptides, Bois-Guillaume, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
